Individualised 177 Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
作者: Anna SundlövKatarina Sjögreen-GleisnerJohanna SvenssonMichael LjungbergTomas OlssonPeter BernhardtJan Tennvall
作者单位: 1Lund University
2Skåne University Hospital
3Sahlgrenska University Hospital
4University of Gothenburg
刊名: European Journal of Nuclear Medicine and Molecular Imaging, 2017, Vol.44 (9), pp.1480-1489
来源数据库: Springer Journal
DOI: 10.1007/s00259-017-3678-4
关键词: 177Lu-DOTATATENeuroendocrineDosimetryPRRTRenal function
英文摘要: To present data from an interim analysis of a Phase II trial designed to determine the feasibility, safety, and efficacy of individualising treatment based on renal dosimetry, by giving as many cycles as possible within a maximum renal biologically effective dose (BED).
原始语种摘要: To present data from an interim analysis of a Phase II trial designed to determine the feasibility, safety, and efficacy of individualising treatment based on renal dosimetry, by giving as many cycles as possible within a maximum renal biologically effective dose (BED).
全文获取路径: Springer  (合作)
分享到:
来源刊物:

×
关键词翻译
关键词翻译
  • neuroendocrine 神经内分泌的
  • dosimetry 剂量测定
  • interim 临时的
  • treatment 处理
  • renal 肾的
  • feasibility 可行性
  • based 基于
  • trial 试验
  • efficacy 效验
  • kidney 肾脏